Company intelligence / Profile preview

aap Implantate

Berlin, Berlin, Germanyaap.de ↗

Ownership: Private
Development stage: Commercial

Overview

aap Implantate is an established German medtech company specializing in the development and commercialization of innovative trauma implants and plating systems for bone fracture management. Its LOQTEQ platform is CE-marked and FDA-cleared, with broad international distribution. The company also develops next-generation antibacterial coatings and absorbable magnesium implants to address infection risk and reduce the need for follow-up surgeries[1][2][3].

Therapeutic areas: OtherRheumatology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Distribution partnerships with global orthopedic companies; broad distributor network in ~25 countries; hybrid direct/distributor model in US market[2]

Beyond the preview

Go deeper on aap Implantate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on aap Implantate.

Explore the full profile